Insights

More Articles Back to Article

Phase I trial results for Jannsen's Zika vaccine are out

Data from an early-stage trial testing the Zika vaccine developed by Johnson & Johnson's unit Janssen showed it induced immunity against the virus for up to 12 months in 80% of recipients, based on results reported in the journal Annals of Internal Medicine. A midstage trial is currently ongoing, the manufacturer said. United Press International (2/15)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!